Alpine Global Management’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,648
Closed -$291K 455
2024
Q2
$291K Buy
+22,648
New +$364K 0.05% 244

Other funds holding TRML

Alpine Global Management's TRML Position: Q3 2024 in Review

Alpine Global Management sold out of Tourmaline Bio (TRML) in Q3 2024, closing a stake of 22,648 shares — an estimated $291K sold.

Alpine Global Management first reported a position in TRML in Q2 2024 and held it in 1 quarter. The position peaked at $291K in Q2 2024. 92 funds tracked by Wall St. Rank hold TRML as of Q3 2024.

  • Alpine Global Management reported no remaining Tourmaline Bio position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 22,648 Tourmaline Bio shares in Q3 2024, an estimated $291K.
  • Alpine Global Management first reported a position in Tourmaline Bio in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's Tourmaline Bio position peaked at $291K in Q2 2024.
  • 92 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.